A detailed history of Vestal Point Capital, LP transactions in Bruker Corp stock. As of the latest transaction made, Vestal Point Capital, LP holds 440,000 shares of BRKR stock, worth $18.3 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
440,000
Previous 500,000 12.0%
Holding current value
$18.3 Million
Previous $20.6 Billion 30.6%
% of portfolio
0.65%
Previous 1.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$29.35 - $43.93 $1.76 Million - $2.64 Million
-60,000 Reduced 12.0%
440,000 $14.3 Billion
Q2 2025

Aug 14, 2025

BUY
$35.5 - $42.18 $7.1 Million - $8.44 Million
200,000 Added 66.67%
500,000 $20.6 Billion
Q1 2025

May 15, 2025

BUY
$41.74 - $62.95 $12.5 Million - $18.9 Million
300,000 New
300,000 $12.5 Billion
Q3 2024

Nov 14, 2024

BUY
$60.3 - $70.67 $7.54 Million - $8.83 Million
125,000 New
125,000 $8.63 Billion

Others Institutions Holding BRKR

About BRUKER CORP


  • Ticker BRKR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 148,138,000
  • Market Cap $6.17B
  • Description
  • Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools, ...
More about BRKR
Track This Portfolio

Track Vestal Point Capital, LP Portfolio

Follow Vestal Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestal Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Vestal Point Capital, LP with notifications on news.